TECX
Tectonic Therapeutic, Inc.
NASDAQ: TECX · HEALTHCARE · BIOTECHNOLOGY
$27.97
+3.32% today
Updated 2026-04-30
Market cap
$512.68M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.05
Dividend yield
—
52W range
$14 – $36
Volume
0.3M
WallStSmart proprietary scores
28
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$77.89
+178.48%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
2 Strong Buy6 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-14.49M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-32.18M | $-42.82M | $-57.98M | $-74.15M | $-19.23M |
| EPS | — | — | — | — | $-4.05 |
| Free cash flow | $-97.47M | $-40.96M | $-59.24M | $-60.29M | $-14.49M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Tectonic Therapeutic, Inc. trades at $27.97. Our Smart Value Score of 28/100 indicates the stock is weak.
Frequently asked questions
What is Tectonic Therapeutic, Inc.'s stock price?
Tectonic Therapeutic, Inc. (TECX) trades at $27.97.
Is Tectonic Therapeutic, Inc. overvalued?
Smart Value Score 28/100 (Grade F, Strong Sell).
What is the price target of Tectonic Therapeutic, Inc. (TECX)?
The analyst target price is $77.89, representing +178.5% upside from the current price of $27.97.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-37.80%
Beta—
50D MA$28.63
200D MA$22.00
Shares out0.02B
Float0.01B
Short ratio—
Avg volume0.3M
Performance
1 week+3.26%
1 month-2.76%
3 months+40.11%
YTD+36.82%
1 year—
3 years—
5 years—